# TRT as an Adjunctive ERAS Therapy in ESRD Patients Undergoing Kidney Transplantation

> **NCT07287800** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of California, Los Angeles** · enrollment: 50 (estimated)

## Conditions studied

- Hypogonadism, Male
- End Stage Renal Disease (ESRD)
- Kidney Transplant

## Interventions

- **DRUG:** Testosterone Replacement Therapy

## Key facts

- **NCT ID:** NCT07287800
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2026-06
- **Final completion:** 2027-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07287800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07287800, "TRT as an Adjunctive ERAS Therapy in ESRD Patients Undergoing Kidney Transplantation". Retrieved via AI Analytics 2026-09-12 from https://api.ai-analytics.org/clinical/NCT07287800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*